S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
XNCR · Xencor, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$25.18
+0.21
(+0.84%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$25.18
$24.42
$25.26
52-WEEK RANGE
$25.18
$10.38
$30.61
What's happening
- XNCR is up 0.84% today, trading at $25.18. — Live quote
- Volume today (47,779) is well below its 3-month average of 1,264,770. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.29 actual vs. $-0.85 estimated (+65.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 11
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
XNCR
+62.90%
vs S&P 500
+50.12%
1-YEAR RETURN
XNCR
+65.49%
vs S&P 500
+50.93%
6-MONTH RETURN
XNCR
+100.32%
3-MONTH RETURN
XNCR
+21.96%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.29
Est. $-0.85
BEAT +65.9%
2026-04-26 (Q1 2026)
$-1.71
Est. $-0.79
MISS -117.5%
2026-01-26 (Q4 2025)
$-0.09
Est. $-0.62
BEAT +85.4%
2025-10-26 (Q3 2025)
$-0.08
Est. $-0.70
BEAT +88.6%
Valuation Measures & Ratios
Enterprise Value4$1.94B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)17.91
Price / Book72.37
EV4 / Revenue18.49
EV4 / EBITDA31.92
Profit Margin-155.59%
Operating Margin-208.93%
Return on Equity (ROE8)-28.66%
Return on Assets (ROA9)-20.38%
Avg Volume (3M)1,264,770
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.21B | $906.9M | $883.0M | $591.3M | $779.8M |
| P/E | -6.43 | -4.23 | -6.71 | -3.07 | -3.31 |
| Price/Sales | 10.02 | 8.90 | 7.67 | 5.01 | 8.62 |
| Price/Book | 2.40 | 1.76 | 1.41 | 0.95 | 1.22 |
| EV/Revenue | 10.30 | 9.57 | 8.19 | 5.44 | 9.31 |
| EV/EBITDA | -6.68 | -5.10 | -5.61 | — | — |
| ROE | -37.26% | -41.54% | -21.04% | -31.09% | -36.80% |
| ROA | -25.86% | -29.07% | -15.14% | -21.93% | -26.03% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short16,368,875
Change from Prior Settlement+3.92%
% of Float—
Days to Cover (Short Ratio)10.11
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 17.5% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +65.5%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -155.6%. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-08-05; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on XNCR
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.2M | $4.5M | $21.0M | $43.6M | $32.7M | $17.8M | $23.9M | $16.0M |
| Operating income | -$37.1M | -$77.9M | -$47.5M | -$33.2M | -$43.2M | -$55.2M | -$55.4M | -$54.7M |
| Net income | -$21.7M | -$128.9M | -$6.0M | -$30.8M | -$48.4M | -$46.3M | -$67.3M | -$73.4M |
| EPS (diluted) | $-0.29 | $-1.71 | $-0.08 | $-0.41 | $-0.66 | $-0.72 | $-1.09 | $-1.20 |
| EPS (basic) | $-0.29 | $-1.71 | $-0.08 | $-0.41 | $-0.66 | $-0.72 | $-1.09 | $-1.20 |
| Operating margin | -$72 | -$1.7K | -$226 | -$76 | -$132 | -$310 | -$232 | -$342 |
| Net margin | -$42 | -$2.9K | -$29 | -$71 | -$148 | -$260 | -$282 | -$459 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $725.0M | $736.8M | $875.5M | $868.8M | $879.4M | $904.7M | $951.9M | $983.6M |
| Total liabilities | $221.7M | $221.2M | $239.9M | $243.5M | $259.1M | $264.8M | $277.9M | $262.7M |
| Stockholders' equity | $503.2M | $515.6M | $635.6M | $625.3M | $620.4M | $639.9M | $677.6M | $723.8M |
| Total current assets | $523.2M | $482.9M | $599.8M | $518.4M | $513.1M | $521.3M | $577.6M | $573.3M |
| Total current liabilities | $81.9M | $73.5M | $95.9M | $86.5M | $96.1M | $88.4M | $87.4M | $92.0M |
| Cash & equivalents | $44.7M | $14.2M | $54.1M | $28.3M | $44.4M | $39.7M | $40.9M | $29.0M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $42.2M | $12.0M | $29.3M | $21.8M | $47.6M | $37.8M | $60.8M | $10.2M |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $50.0M | $51.5M | $53.3M | $54.6M | $56.8M | $58.8M | $59.8M | $62.4M |
| Intangible assets | $6.5M | $7.6M | $8.4M | $9.5M | $11.3M | $13.4M | $18.5M | $17.9M |
| Other non-current assets | $498.0K | $498.0K | $498.0K | $498.0K | $498.0K | $498.0K | $498.0K | $498.0K |
| Accounts payable | $12.6M | $7.9M | $10.8M | $9.1M | $18.5M | $16.2M | $16.8M | $18.8M |
| Accrued liabilities | $36.4M | $34.3M | $35.0M | $28.1M | $23.9M | $16.1M | $19.2M | $25.4M |
| Deferred revenue (current) | — | — | — | — | — | — | $0 | $0 |
| Long-term debt | $77.5M | $82.1M | $76.5M | $87.8M | $94.7M | $101.8M | $115.2M | $10.2M |
| Other non-current liabilities | $152.0K | $152.0K | $0 | — | — | — | — | — |
| Common stock & paid-in capital | $744.0K | $741.0K | $718.0K | $714.0K | $714.0K | $712.0K | $703.0K | $701.0K |
| Retained earnings | -$946.6M | -$924.9M | -$796.0M | -$789.3M | -$783.3M | -$752.5M | -$704.0M | -$643.5M |
| Accumulated other comprehensive income (loss) | -$872.0K | $27.0K | $1.6M | $1.2M | $258.0K | $355.0K | -$663.0K | $1.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$55.7M | -$67.6M | -$51.7M | -$30.8M | -$36.4M | -$16.2M | -$49.8M | -$28.1M |
| Investing cash flow | $85.1M | $26.7M | $71.2M | $14.7M | $40.5M | $13.7M | $57.3M | -$163.5M |
| Financing cash flow | $1.0M | $950.0K | $6.3M | $0 | $662.0K | $1.2M | $4.4M | $189.9M |
| Free cash flow | -$56.2M | -$68.2M | -$52.9M | -$31.0M | -$36.8M | -$17.7M | -$51.5M | -$29.4M |
| Capital expenditures | $538.0K | $610.0K | $1.1M | $183.0K | $383.0K | $1.4M | $1.7M | $1.3M |
| Depreciation & amortization | $2.4M | $2.6M | $2.6M | $2.6M | $2.7M | $2.7M | $3.0M | $3.1M |
| Share-based compensation | $9.2M | $9.6M | $31.0M | $10.1M | $10.7M | $12.2M | $41.9M | $12.3M |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $28.4M | -$5.8M | -$14.1M | — | $8.8M | -$23.4M | $32.7M | — |
| Change in accounts payable | $4.5M | -$2.9M | $1.7M | -$9.5M | $4.4M | -$568.0K | -$2.0M | $2.9M |
| Purchases of investments | $0 | $72.7M | $37.9M | $84.2M | $72.9M | $103.9M | $54.2M | $281.7M |
| Sales/maturities of investments | $30.7M | — | — | — | $0 | — | $24.7M | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $125.6M | $110.5M | $174.6M | $164.6M | $275.1M |
| Operating income | -$177.5M | -$178.4M | -$132.4M | -$82.5M | $43.8M |
| Net income | -$91.9M | -$232.6M | -$133.1M | -$55.2M | $82.6M |
| EPS (diluted) | $-1.24 | $-3.58 | $-2.20 | $-0.93 | $1.37 |
| EPS (basic) | $-1.24 | $-3.58 | $-2.20 | $-0.93 | $1.42 |
| Operating margin | -$141 | -$161 | -$76 | -$50 | $16 |
| Net margin | -$73 | -$211 | -$76 | -$34 | $30 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $875.5M | $951.9M | $965.1M | $846.3M | $838.2M |
| Total liabilities | $239.9M | $277.9M | $303.0M | $118.8M | $104.7M |
| Stockholders' equity | $635.6M | $677.6M | $661.8M | $727.5M | $733.5M |
| Total current assets | $599.8M | $577.6M | $635.6M | $675.3M | $424.4M |
| Total current liabilities | $95.9M | $87.4M | $73.9M | $63.8M | $70.7M |
| Cash & equivalents | $54.1M | $40.9M | $53.8M | $53.9M | $143.5M |
| Marketable securities (current) | — | — | — | — | — |
| Accounts receivable | $29.3M | $60.8M | $23.7M | $29.0M | $66.4M |
| Marketable securities (non-current) | — | — | — | — | — |
| Property, plant & equipment | $53.3M | $59.8M | $66.1M | $59.2M | $28.2M |
| Intangible assets | $8.4M | $18.5M | $18.7M | $18.5M | $16.5M |
| Other non-current assets | $498.0K | $498.0K | $648.0K | $613.0K | $653.0K |
| Accounts payable | $10.8M | $16.8M | $13.9M | $10.1M | $14.0M |
| Accrued liabilities | $35.0M | $19.2M | $23.6M | $18.7M | $19.4M |
| Deferred revenue (current) | — | $0 | $0 | $30.3M | $37.3M |
| Long-term debt | $76.5M | $115.2M | $161.8M | $0 | — |
| Common stock & paid-in capital | $718.0K | $703.0K | $611.0K | $601.0K | $595.0K |
| Retained earnings | -$796.0M | -$704.0M | -$471.4M | -$338.3M | -$283.1M |
| Accumulated other comprehensive income (loss) | $1.6M | -$663.0K | $1.3M | -$7.0M | -$1.5M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$135.1M | -$202.2M | -$77.9M | $24.5M | -$16.9M |
| Investing cash flow | $140.0M | -$7.9M | -$111.1M | -$119.7M | -$46.2M |
| Financing cash flow | $8.2M | $197.2M | $189.2M | $5.7M | $43.0M |
| Free cash flow | -$138.3M | -$208.3M | -$96.4M | -$14.0M | -$30.2M |
| Capital expenditures | $3.1M | $6.1M | $18.4M | $38.5M | $13.3M |
| Depreciation & amortization | $10.5M | $12.1M | $11.5M | $8.8M | $7.5M |
| Share-based compensation | $43.2M | $53.3M | $53.8M | $48.9M | $37.0M |
| Deferred income taxes | $0 | $0 | $0 | $0 | — |
| Change in accounts receivable | -$28.7M | $32.7M | -$19.8M | — | — |
| Change in accounts payable | -$4.0M | $2.8M | $3.8M | -$3.9M | $5.0M |
| Purchases of investments | $298.9M | $595.1M | $782.9M | $387.9M | $509.6M |
| Sales/maturities of investments | — | $24.7M | $0 | $0 | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding XNCR as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers99.7%
Shares Outstanding75,859,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,651,261 | $219.8M | 18.00% | +4.7% | 2026-08-07 |
| PRIMECAP MANAGEMENT CO/CA/ | 10,181,322 | $163.9M | 13.42% | -1.5% | 2026-08-14 |
| BVF INC/IL | 7,133,720 | $114.9M | 9.40% | +0.0% | 2026-08-14 |
| RTW INVESTMENTS, LP | 6,777,461 | $109.1M | 8.93% | +0.0% | 2026-08-14 |
| RA CAPITAL MANAGEMENT, L.P. | 5,274,274 | $84.9M | 6.95% | +7.7% | 2026-08-14 |
| State Street Corp | 4,954,016 | $79.8M | 6.53% | +13.8% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,278,802 | $52.8M | 4.32% | +5.7% | 2026-06-30 |
| TCG Crossover Management, LLC | 2,452,138 | $39.5M | 3.23% | +0.0% | 2026-08-12 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,356,409 | $37.9K | 3.11% | +51.0% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,215,690 | $35.7M | 2.92% | -36.7% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,920,859 | $30.9M | 2.53% | +5.8% | 2026-08-12 |
| Morgan Stanley | 1,752,556 | $28.2M | 2.31% | +12.5% | 2026-08-11 |
| UBS Group AG | 1,306,174 | $21.0M | 1.72% | +20.7% | 2026-08-13 |
| BAKER BROS. ADVISORS LP | 1,102,106 | $17.7M | 1.45% | +0.0% | 2026-08-14 |
| Legal & General Group Plc | 1,091,177 | $17.6M | 1.44% | +2.3% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 1,011,119 | $16.3M | 1.33% | -21.9% | 2026-08-11 |
| Goldman Sachs Group Inc | 968,778 | $15.6M | 1.28% | +26.8% | 2026-08-14 |
| MILLENNIUM MANAGEMENT LLC | 853,677 | $13.7M | 1.13% | +40.0% | 2026-08-14 |
| TWO SIGMA INVESTMENTS, LP | 819,515 | $13.2M | 1.08% | +1.7% | 2026-08-07 |
| Northern Trust Corp | 794,279 | $12.8M | 1.05% | +6.7% | 2026-08-12 |
| Johnson & Johnson | 748,062 | $12.0M | 0.99% | +0.0% | 2026-08-06 |
| Jefferies Financial Group Inc. | 720,440 | $11.6M | 0.95% | +0.0% | 2026-08-14 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 707,242 | $11.4M | 0.93% | +1.5% | 2026-08-14 |
| PANAGORA ASSET MANAGEMENT INC | 680,182 | $11.0M | 0.90% | +9.6% | 2026-08-06 |
| Deep Track Capital, LP | 593,551 | $9.6M | 0.78% | +0.0% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-12-19 to 2026-06-18
Recent transactions
- Insiders have net sold 30,382 shares over the last 182 days, across 0 purchases and 5 sales.
- Most recent: Feigal Ellen (Director) — Open market sale of 6,843 shares on 2026-06-18.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)30,382 sh(5 txns)
Net Shares-30,382
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Feigal Ellen | Director | Open market sale | 2026-06-18 | 6,843 |
| GORMAN KEVIN CHARLES | Director | Grant / award | 2026-06-16 | 10,302 |
| GUSTAFSON KURT A | Director | Grant / award | 2026-06-16 | 10,302 |
| Klencke Barbara | Director | Grant / award | 2026-06-16 | 10,302 |
| Montgomery Alan Bruce | Director | Grant / award | 2026-06-16 | 10,302 |
| RANIERI RICHARD J | Director | Grant / award | 2026-06-16 | 10,302 |
| SIMPSON TODD E | Director | Grant / award | 2026-06-16 | 10,302 |
| Deshaies Raymond Joseph | Director | Grant / award | 2026-06-16 | 10,302 |
| Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | Open market sale | 2026-04-10 | 3,499 |
| Desjarlais John R | SR. VICE PRESIDENT & CSO | Open market sale | 2026-03-06 | 2,502 |
| Eckert Celia | SVP, GENERAL COUNSEL | Open market sale | 2026-03-06 | 1,767 |
| Dahiyat Bassil I | PRESIDENT & CEO | Open market sale | 2026-03-06 | 6,606 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-18 | Feigal Ellen | Director | Open market sale | 6,843 | $13.06 |
| 2026-06-16 | Feigal Ellen | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | GORMAN KEVIN CHARLES | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | GUSTAFSON KURT A | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | Klencke Barbara | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | Montgomery Alan Bruce | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | RANIERI RICHARD J | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | SIMPSON TODD E | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-16 | Deshaies Raymond Joseph | Director | Grant / award | 10,302 | $0.00 |
| 2026-06-15 | GORMAN KEVIN CHARLES | Director | Open market sale | 7,527 | $12.31 |
| 2026-06-15 | GUSTAFSON KURT A | Director | Open market sale | 5,474 | $12.31 |
| 2026-06-15 | RANIERI RICHARD J | Director | Open market sale | 5,474 | $12.31 |
| 2026-06-15 | Montgomery Alan Bruce | Director | Open market sale | 5,064 | $12.31 |
| 2026-04-10 | Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | Open market sale | 3,499 | $12.29 |
| 2026-03-06 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Open market sale | 2,502 | $11.02 |
| 2026-03-06 | Eckert Celia | SVP, GENERAL COUNSEL | Open market sale | 1,767 | $11.02 |
| 2026-03-06 | Dahiyat Bassil I | PRESIDENT & CEO | Open market sale | 6,606 | $11.02 |
| 2026-03-05 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Open market sale | 4,118 | $11.25 |
| 2026-03-05 | Eckert Celia | SVP, GENERAL COUNSEL | Open market sale | 3,244 | $11.25 |
| 2026-03-05 | Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | Open market sale | 2,517 | $11.25 |
| 2026-03-05 | Dahiyat Bassil I | PRESIDENT & CEO | Open market sale | 14,870 | $11.25 |
| 2026-03-03 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Open market sale | 2,663 | $11.90 |
| 2026-03-03 | Eckert Celia | SVP, GENERAL COUNSEL | Open market sale | 1,492 | $11.90 |
| 2026-03-03 | Dahiyat Bassil I | PRESIDENT & CEO | Open market sale | 6,758 | $11.90 |
| 2026-03-02 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Grant / award | 24,907 | $0.00 |
| 2026-03-02 | Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | Grant / award | 19,458 | $0.00 |
| 2026-03-02 | Eckert Celia | SVP, GENERAL COUNSEL | Grant / award | 18,680 | $0.00 |
| 2026-03-02 | Dahiyat Bassil I | PRESIDENT & CEO | Grant / award | 97,291 | $0.00 |
| 2026-01-23 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Option exercise | 5,322 | $12.51 |
| 2025-12-22 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Option exercise | 6,311 | $12.51 |
| 2025-12-22 | Dahiyat Bassil I | PRESIDENT & CEO | Option exercise | 10,624 | $12.51 |
| 2025-12-19 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Option exercise | 73,367 | $12.51 |
| 2025-12-19 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Open market sale | 73,367 | $15.72 |
| 2025-12-19 | Dahiyat Bassil I | PRESIDENT & CEO | Option exercise | 114,377 | $12.51 |
| 2025-12-19 | Dahiyat Bassil I | PRESIDENT & CEO | Open market sale | 114,377 | $15.71 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:17 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-29 | 8-K | 2026-07-29 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-18 | View on SEC.gov → |
Recent news
Headlines about XNCR (Xencor, Inc.). Links open the publisher — we don’t host full articles.
-
Xencor, Inc. (XNCR) Stock Forecasts
Yahoo Finance · 2026-10-22 -
Xencor's (XNCR) Outperform Rating Reaffirmed at Wedbush
MarketBeat · 2026-10-21 -
Wedbush Reiterates Outperform on Xencor, Maintains $30 Price Target
Benzinga · 2026-10-21 -
Xencor, Inc. (XNCR) - What Are Researchers Saying About This Stock?
MarketBeat · 2026-10-21 -
Xencor schedules XmAb819 webcast: Wells Fargo targets Xencor stock at USD 30
AD HOC NEWS · 2026-10-20 -
Learn Why The Bull Case For Xencor Stock Could Change Following Phase 1 Cancer Results
Simply Wall Street · 2026-10-20 -
Is Xencor (XNCR) A Bargain After Its XmAb819 Phase 1 Update?
Yahoo · 2026-10-19 -
Xencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
Yahoo · 2026-10-19
No headlines in this category right now — try “All”.